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Abstract
Background: Although premature neonates (PN) gut microbiota has been studied, data about gut clostridial colonization in
PN are scarce. Few studies have reported clostridia colonization in PN whereas Bacteroides and bifidobacteria have been
seldom isolated. Such aberrant gut microbiota has been suggested to be a risk factor for the development of intestinal
infections. Besides, PN are often treated by broad spectrum antibiotics, but little is known about how antibiotics can
influence clostridial colonization based on their susceptibility patterns. The aim of this study was to report the distribution
of Clostridium species isolated in feces from PN and to determine their antimicrobial susceptibility patterns. Additionally,
clostridial colonization perinatal determinants were analyzed.
Results: Of the 76 PN followed until hospital discharge in three French neonatal intensive care units (NICUs), 79% were
colonized by clostridia. Clostridium sp. colonization, with a high diversity of species, increased throughout the
hospitalization. Antibiotic courses had no effect on the clostridial colonization incidence although strains were found
susceptible (except C. difficile) to anti-anaerobe molecules tested. However, levels of colonization were decreased by either
antenatal or neonatal (during more than 10 days) antibiotic courses (p=0.006 and p=0.001, respectively). Besides,
incidence of colonization was depending on the NICU (p=0.048).
Conclusion: This study shows that clostridia are part of the PN gut microbiota. It provides for the first time information on
the status of clostridia antimicrobial susceptibility in PN showing that strains were susceptible to most antibiotic molecules.
Thus, the high prevalence of this genus is not linked to a high degree of resistance to antimicrobial agents or to the use of
antibiotics in NICUs. The main perinatal determinant influencing PN clostridia colonization appears to be the NICU
environment.
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Introduction
Clostridia are gram-positive endospore-forming obligate anaer-
obes, found in the environment, and are common inhabitants of
the human and animal intestinal microbiota. This genus is of
medical importance as many species are responsible for several
diseases in adults and children. Clostridial infections are either
from exogenous sources such as food-borne diseases (Clostridium
perfringens or Clostridium botulinum), wound infections (C. perfringens),
hospital-acquired infections (Clostridium difficile antibiotic associated
diarrhea or pseudomembranous colitis), or from the host’s
endogenous microbiota [1]. These latter clostridial infections,
often in association with various bacterial species, tend to be more
severe than comparable infections without clostridia [1]. In
neonates, asymptomatic carriage of toxigenic or non toxigenic
clostridia in the digestive tract has been reported, but it may also
be associated with infections [2,3]. The incidence of anaerobes in
neonatal bacteraemia varies between 1.8 and 12.5%, among
which about one third are due to clostridia, mostly C. perfringens [3].
Clostridia are supposed to be involved in necrotizing enteroco-
litis (NEC) in premature neonates (PN), a devastating gastrointes-
tinal disease with high morbidity and mortality [4–9]. However,
recent data did not confirm clostridia and NEC association [10].
Nevertheless, C. perfringens, Clostridium butyricum,o rClostridium
paraputrificum have been isolated from the blood, feces, and
peritoneal fluids of PN suffering from NEC [5,11–13]. Early gut
colonization by C. perfringens has been associated with NEC [14,15]
and Clostridium neonatale with a NEC outbreak [7]. Moreover, C.
butyricum, C. perfringens and C. paraputrificum were shown to be
responsible for cecal NEC-like lesions through bacterial fermen-
tation end-products in quail animal model of NEC [16]. More
recently, Smith et al. [17] reported a correlation between the
presence of C. butyricum and C. paraputrificum and pneumatosis
intestinalis in tissue specimens from PN with NEC. All together,
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pathogens or secondary invaders in NEC. However, despite
similarities between NEC and clostridial infection, isolation of
clostridia is rarely performed routinely in PN.
If PN gut microbiota has been studied, data about gut clostridial
colonization in PN are scare. Few studies have reported clostridia
colonization in PN whereas Bacteroides and bifidobacteria have
been seldom isolated [18–20]. Such aberrant gut microbiota has
been suggested to be a risk factor for the development of intestinal
infections such NEC [21,22]. Besides, PN are often treated by
broad spectrum antibiotics, but little is known about how
antibiotics can alter clostridial colonization based on their
susceptibility patterns. The aim of this study was therefore to
report the distribution of Clostridium species isolated in feces from
PN and to determine their antimicrobial susceptibility patterns.
Statistical analysis was performed to investigate clostridial
colonization perinatal determinants.
Materials and Methods
Study and population
This retrospective study included 76 PN born in three
independent French neonatal intensive care units (NICUs) from
2002 to 2007. PN in this study had been included in random
controlled trials (with control groups) to evaluate the effects of
premature neonatal formula, which have been demonstrated to
have no effect on intestinal bacteria colonization [18], except for
colonization by the two probiotic strains [19]. In those studies, to
be eligible for enrolment, PN must have been born at gestational
age (GA),36 weeks (wk) and without any malformations or
metabolic diseases. Written informed parental consent was
obtained for each PN before inclusion. The protocol was approved
by the local Institutional Review Board [18,19]. PN were enrolled
during their first 3 days of life until hospital discharge.
Microbiological analysis of fecal samples
Fecal samples, collected weekly during hospitalization from
diapers, were placed in sterile tubes, frozen and kept at 280uC
until analyzed. Fecal microbiota analysis was performed using
culture and PCR-temporal temperature gradient electrophoresis,
as in previously studies [18,19]. For quantitative analysis of
clostridia, 0.1 to 0.5 mg of frozen fecal samples were crushed in
Brain Heart Infusion broth using an Ultra-Turrax T25 (Fisher-
Bioblock, Illkirch, France) apparatus. After dilution in peptone
water, 10
22,1 0
24 and 10
26 dilutions were spread using the
WASPH apparatus (AES Chemunex, Bruz, France) on cysteine
(160 mg/L) Columbia agar base supplemented with sheep blood
5% [23], and whole milk 5%, colistin (10 mg/L) and neutral red
(40 mg/L) for all clostridia [24] and C. difficile supplement
(bioMe ´rieux, Marcy l’Etoile, France) for C. difficile. Media
incubation was performed for 48 h at 37uC in an anaerobic
chamber (MACSH, AES Chemunex) under anaerobic gas phase
(H2:CO2:N2, 10:10:80, vol/vol/vol). Bacterial counts were
expressed as the log10 colony forming units (CFU)/g of feces,
and the count threshold was 3 log10 CFU/g of feces.
Strain identification
Colonies that were able to grow on the selective medium and
suspected to be clostridia on the basis of cellular morphology and
Gram staining were identified using Rapid ID 32A strips
(bioMe ´rieux). Identification of each isolate was confirmed by
partial sequencing of 16S rRNA gene, which was amplified by
PCR using primers LPW58 (59-AGGCCCGGGAACGTATT-
CAC-39) and LPW81 (59-TGGCGAACGGGTGAGTAA-39)
[25]. PCR conditions were as follows: PCR mixture was composed
of 1 mM of each primer, 5% of DMSO, each deoxynucleotide
triphosphate at a concentration of 250 mMi n1 6PCR buffer and
1.25 U of recombinant DNA polymerase (Invitrogen, Illkirch,
France) in a final volume of 25 ml. The PCR program was 30 s at
95uC, followed by 40 cycles of 1 min at 94uC, 1 min at 55uC,
2 min at 72uC and a 10 min final extension at 72uC. PCR
products were then sequenced (Beckman Coulter Genomics,
Takeley, United Kingdom).
Antibiotics susceptibility testing
Clostridia antibiotic susceptibility testing was performed using
the disk-diffusion method on Brucella agar medium supplemented
with 5% of laked sheep blood and 1 mg of vitamin K1/mL
according to the recommendations of the Comite ´ de l’Antibio-
gramme de la Socie ´te ´ Franc ¸aise de Microbiologie [26]. The
antibiotic disks (bioMe ´rieux) used were amoxicillin, amoxicillin-
clavulanic acid, piperacillin, piperacillin-tazobactam, ertapenem,
imipenem, cefoxitine, cefotaxim, clindamycine, tetracycline,
tigecycline, chloramphenicol, moxifloxacin, metronidazole, line-
zolide, and vancomycin (Bio-Rad, Marnes la Coquette, France).
When necessary, MICs for amoxicillin, piperacillin, piperacillin/
tazobactam, ertapenem, cefotaxim, metronidazole, tetracycline,
and tigecycline were determined using E-test strips as specified by
the manufacturer (bioMe ´rieux).
Statistical analysis
Statistical analysis was performed using SPSSH 15.0 software.
Student’s t test, or Mann-Whitney when appropriate, were used
for comparison of continuous variables and Chi-2 test or Fisher’s
exact test when appropriate, was used for comparison of
categorical variables. Univariate analysis and multivariate regres-
sion analysis were used to evaluate the relationship between
perinatal (first week of life) and neonatal characteristics (at hospital
discharge), i.e. GA, mode of delivery, antenatal, intrapartum or
neonatal antibiotic treatments, and NICUs. All tests were two-
tailed and p-values less than 0.05 were considered significant.
Results
Population characteristics
Table 1 lists the characteristics of the 76 PN included in this
study. The PN were born at a median gestational age of 32.8 wk
[interquartile, 29–34 wk] and had a median birth weight of
1695 g [interquartile, 1313–2103 g]. They were followed from
birth until hospital discharge (median 4 wk, [interquartile 2.3–
5.0 wk]). No PN were suffering from NEC.
Among the 76 PN, 29 PN (38.2%) were born from mothers who
received antenatal treatment within 8 days before birth with the
following antibiotics used either alone or in combination:
amoxicillin (82.7%), gentamicin (27.6%), metronidazole (10.3%),
clindamycin (6.9%), amoxicillin-clavulanic acid (6.9%), and not
documented (17.2%). Thirty-two PN (42.1%) were born from
mothers receiving intrapartum antibiotic therapy using: amoxicil-
lin (87.5%), gentamicin (56.2%), cefixime (3.1%), cefazoline
(3.1%), erythromycin (3.1%), and not documented (9.3%). Forty-
one PN (54%) underwent neonatal antibiotic therapy for suspected
(n=17) or confirmed infection (n=24). Prescriptions were
administered for a median of 5 d [interquartile 2–11.5 d] and
comprised amoxicillin (80.5%), cefotaxime (85.4%), aminoglyco-
side (gentamicin or amikacin) (80.5%), vancomycin (29.3%),
metronidazole (9.7%), macrolide (josamycin or erythromycin)
(9.7%), imipenem (7.3%), and oxacillin (2.4%).
Gut Clostridial Colonization in Premature Neonates
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30594Clostridial colonization
In the current study, of the 271 fecal samples analyzed (average
of 3.6 samples per neonate), 237 clostridia strains were isolated
and corresponded to 130 non redundant Clostridium strains. Non
redundant strains were defined as strains isolated from one
individual and belonging to one species. At hospital discharge, 60
out of the 76 PN (78.9%) were colonized with clostridia species at
levels ranging from 3.3 to 9.2 log10 CFU/g feces (Fig. 1A). The
proportion of PN colonized by Clostridium sp increased throughout
the hospitalization period: 27.5% were colonized after the first
week of life, 78.9% at wk 4, and 100% of the PN hospitalized after
wk 7 (Fig. 1A). PN were colonized with one (n=18), two (n=23),
three (n=10), or up to 4 (n=9) different clostridia species. The
most frequently recovered species were C. perfringens (46.1% of the
PN), C. butyricum (44.7%), C. difficile (42.1%), and C. paraputrificum
(22.4%). Other recovered species were as follows: C. baratii (3.9%
of the PN), C. tertium (3.9%), C. disporicum (2.6%), Robinsoniella
peoriensis (2.6%) C. glycolicum (1.3%) or C. orbiscindens (Flavonifractor
plautii) (1.3%) (Fig. 1B).
Clostridial antimicrobial susceptibility
Antimicrobial susceptibility levels of all the isolates (n=237) was
performed. Table 2 presents the data for the 139 non duplicate
strains. Duplicate strains were defined as strains isolated from the
same PN and belonging to the same bacterial species and for
which no major discrepancies in antibiotic susceptibility (suscep-
tible versus resistant, or the reverse) were found throughout the
study period. All the strains tested were susceptible to amoxicillin-
clavulanic acid, piperacillin-tazobactam, chloramphenicol, metro-
nidazole, linezolid, and vancomycin. Overall, strains were resistant
to clindamycin (51.8% of the strains), cefotaxim (38.1%),
tetracycline (17.3%), and moxifloxacin (1.4%) (Table 2). Interme-
diate phenotypes to moxifloxacin, cefotaxim and imipenem
represented respectively 49.6, 18.0, and 1.4% of the strains
(Table 2). Resistance to cefotaxim was observed for all C. difficile
strains and 42.5% of the C. butyricum strains. In addition to
cefotaxim, some of the C. butyricum strains were resistant to
amoxicillin (7.5%) and piperacillin (12.5%) (Table 2). Based on the
nitrocefin assay, these latter resistant strains (n=5) showed a b-
lactamase. Resistance to clindamycin was observed for C. difficile
(97.0% of the isolates), C. paraputrificum (94.1%), C. perfringens
(40.5%), and C. butyricum (2.5%) (Table 2). Tetracycline resistance
was distributed among strains of C. perfringens (32.4% of the strains),
C. butyricum (25.0%), and C. difficile (3.0%), and in addition 8.0% of
the C. perfringens strains were resistant to tigecyclin (Table 2).
Concerning moxifloxacin, 94.5% of the C. perfringens isolates
showed an intermediate phenotype. Although, there was no
resistance observed to moxifloxacin, 39.4% of C. difficile strains
were found intermediate (Table 2).
Analysis of clostridial colonization perinatal determinants
Statistical analysis showed no relationships between the
incidence of intestinal clostridial colonization at wk 1 or at
hospital discharge and either GA, or birth weight, or delivery
mode, or antibiotic courses. However, the incidence tended to be
higher in PN born at a GA less than 29 wk (p=0.07). Besides, the
incidence of colonization was higher for PN born in one of the
three NICUs participating to the study. After multivariate logistic
regression analysis, only NICU remained independently associated
with the incidence of colonization (p=0.048) for the NICU
mentioned above.
Comparison of clostridia recovery among antibiotic exposed
and non exposed PN included in the study are presented in Fig. 2.
These data confirm the absence of effect of antibiotics on the
overall clostridial colonization. However, as far as species are
concerned, we observed a significant higher frequency of C.
butyricum isolation (p=0.039) in fecal samples from PN previously
exposed to antibiotics.
When concidering clostridia colonization levels, antenatal
antibiotic treatment significantly decreased clostridia levels
(p=0.006), while intrapartum antibiotic therapy had no effect.
Neonatal antibiotic therapy significantly decreased the levels
(p=0.001) of clostridial colonization only when performed during
more than 10 days (n=11 PN).
Discussion
The present study reports, for the first time, the incidence of
clostridia species colonizing the gut of PN and the perinatal
determinants influencing clostridial colonization. Statistical anal-
ysis showed that the NICU was a major determinant influencing
PN clostridia colonization and that antibiotic courses influenced
the levels of colonization.
This study reports a mean high incidence in clostridial
colonization during hospitalization, since about 80% of the PN
were colonized. Additionally, we showed a sharp increase in this
incidence throughout the hospitalization period: all the PN have
been colonized after wk 7. Studies using either culture [27–30] or
culture-independent [20,31,32] methods previously reported
incidences of colonization ranging from 20–60% and 7–40%,
respectively. Likewise, increase in clostridia colonization through-
out the study period has been previously described by culture
(incidences of 30% at wk 4 of life [29]) or culture-independent
methods (incidence of 45% at wk 7 of life [20] and 32% at 1month
of life [32]). The high incidence of clostridial colonization that we
observed compared to these previous studies may suggest possible
differences in either the studied population in terms of perinatal
characteristics, or nursing conditions, or hospital environment.
A high diversity in species colonizing PN was observed in the
present work. The most frequent species isolated were C. perfringens,
C. butyricum, C. difficile, and C. paraputrificum with fluctuations in
their relative levels. The first three species were previously isolated
in quite similar incidences by culture methods [27,29]. By
contrast, C. paraputrificum was rarely isolated. Comparison of our
data with results obtained through culture-independent studies is
difficult as little data are available concerning clostridia coloniza-
tion. Indeed, culture-independent approaches described clostridia
Table 1. Characteristics of the premature neonates included
in the study.
Population n=76 (Range)
Gestational age, weeks 31.063.3 (24.0–35.9)
Birth weight, g 16566543 (550–2750)
Delivery mode
vaginal delivery 41
caesarean section 35
Maternal antibiotic therapy
antenatal 29
intrapartum 32
Neonatal antibiotic therapy 41
duration, days 9.6610.4 (1–41)
doi:10.1371/journal.pone.0030594.t001
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[10,33,34]. Some studies did not find clostridia at all [35–37].
Most of the approaches were based on PCR techniques using
universal primers or primers designed to amplify the variable 16S
rRNA gene regions. However, the design of primers is challenging
because clostridia belongs to a complex phylogenetic heteroge-
neous group [38,39]. For instance, C. difficile belongs to the cluster
XI of the non group I of Clostridium species while C. butyricum, C.
perfringens,o rC. paraputrificum belong to the cluster I of the group I
of Clostridium species [39]. Additionally, for one cluster a high
genetic diversity among the different strains was reported: C.
perfringens and C. butyricum representative strains were distributed
respectively on 9 and 6 different clusters [38]. Therefore, future
studies on clostridia will need a careful analysis of 16S rRNA
sequences in order to design specific and discriminant probes in
order to search for specific clostridia species.
Quantitative and qualitative analysis of the faecal microbiota on
the PN had been previously described and it showed: (i) high
incidences and levels of staphylococci colonization; (ii) a more or
less delay in colonization by enterobacteria and enterococci; (iii) a
sharp delay in colonization by anaerobic genera (except clostridia)
(for details see [18,19]). In this study we showed that clostridia are
part of the autochthonous gut microbiota of PN. It raises the
question of the risk of clostridia gastro-intestinal induced
pathologies. Indeed, such high incidence of clostridia associated
with the delay in colonization by other anaerobes [18–20] leads to
a dysbiosis of the microbiota in PN that might have health
consequences [37]. The most frequently isolated species - C.
perfringens, C. butyricum, C. paraputrificum - have been implicated in
NEC [37]. But despite NEC’s clinical similarity to clostridial
infection [8] and evidence through animal studies [16], only few
studies searched for anaerobic bacteria. More recently, culture-
independent techniques did not identify significant differences in
the fecal microbiota of PN with and without NEC [35,40], or
reported diminished overall microbial diversity and abundance
[33,41]. One report associated early colonization by C. perfringens
and NEC [15]. Alternatively, novel non identified pathogens
might contribute to the aetiology of NEC [10]. However,
limitations of these culture or culture-independent studies were
either the small number of cases [10,15,33] or the collection of
samples had been obtained after onset of the disease and initiation
of antibiotics treatment [35,40] which limits interpretations.
Moreover, culture-independent techniques did not allow identifi-
cation of bacteria in a subdominant status although it can have
harmful biological effects. While involvement of clostridia in NEC
onset remains questionable [10], it is consistent with the high
concentrations of short chain fatty acids, excessive luminal gas
production, and pneumatosis that are associated with NEC lesions
[16,17,42]. However, since we showed that clostridia belong to the
commensal microbiota of PN, NEC might be induced by likely
Figure 1. Clostridial colonization of the premature neonates included in the study. A. Clostridial colonization of the premature neonates
(n=76) during the first 7 weeks of hospitalization. Bar graphs indicate percentage of colonized premature neonates by clostridia. Line graph indicate
mean levels of colonization by clostridia (log10 colony-forming unit (CFU)/g of feces), with standard deviation represented by vertical bars. B: Number
of premature neonates colonized by the different Clostridium species. Clostridium spp included C. baratii (n=3), C. tertium (n=3), C. disporicum (n=2),
Robinsoniella peoriensis (n=2)C. glycolicum (n=1)orC. orbiscindens (n=1).
doi:10.1371/journal.pone.0030594.g001
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factors associated with the highly immunoreactive intestinal
mucosa of PN [9].
Fear of PN infections often leads to early use of empiric broad-
spectrum antibiotics at the NICUs, a strategy that increases the
risk of colonization with resistant strains [43]. In this study,
antibiotic courses decreased clostridial colonization levels but had
no effect on the colonization incidence. The lack of a strong effect
of antibiotics could not be explained by the resistance pattern of
the clostridial strains. Indeed, C. perfringens strains were susceptible
to almost all molecules tested (except to clindamycin, tetracycline
and tigecycline). C. difficile resistance levels to cefoxitin, cefotaxim,
ertapemen, clindamycin and susceptibility levels to imipenem and
tetracycline were as previously reported for strains isolated from
hospitals [44–46]. No resistance was observed to moxifloxacin,
although it has been described at high frequencies [46], but one
third of our strains were found to be intermediate. Resistance to
amoxicillin and piperacillin was observed for C. butyricum strains
and was attributed to its specific b-lactamase inhibited by
clavulanic acid [47]. Nevertheless, whereas antibiotic courses did
not influence overall clostridia colonization, the PN exposed to
antibiotics were more often colonized with C. butyricum species.
In the current study, statistical analysis was performed to test
whether perinatal determinants could be related with clostridial
colonization. By contrast with full-term neonates [48–50], delivery
mode had no effect on clostridial colonization. This confirms the
previous reports on the limited influence on initial colonization in
PN delivered through caesarean section [20,51]. In our study, the
perinatal determinant influencing clostridia colonization appears
to be the NICU. The fact that clostridial colonization incidence
increased during the hospitalization suggests a colonization from
the environment. Indeed, clostridia, despite being strict anaerobes,
are spore-forming bacteria, which can survive in hospital
environment, such as previously demonstrated for C. difficile [52].
Table 2. Antibiotic resistance phenotypes of the 139 non
duplicate clostridia strains isolated from the feces of the 76
premature neonates included in the study.
Percentage of strains
a
Isolates (number tested) and antibiotics S I R
b
Clostridium perfringens (n=37)
clindamycin 59.5 40.5
tetracyclin 19 48.6 32.4
tigecyclin 86.5 5.5 8.0
moxifloxacin 5.4 94.6
Clostridium difficile (n=33)
imipenem 93.9 6.1
ertapenem 100
cefoxitin 100
cefotaxim 100
clindamycin 3.0 97.0
tetracyclin 94.0 3.0 3.0
moxifloxacin 60.6 39.4
Clostridium butyricum (n=40)
amoxicillin 87.5 5.0 7.5
amoxicillin/clavulanic acid 100
piperacillin 87.5 12.5
cefotaxim 57.5 42.5
clindamycin 97.5 2.5
tetracyclin 75.0 25.0
moxifloxacin 77.5 22.5
Clostridium paraputrificum (n=17)
clindamycin 5.9 94.1
moxifloxacin 64.7 35.3
Clostridium spp
c (n=12)
cefotaxim 58.3 16.7 25.0
clindamycin 33.3 66.7
tetracyclin 91.7 8.3
moxifloxacin 33.3 50.0 16.7
Total of Clostridium strains (n=139)
amoxicillin 96.4 1.4 2.2
piperacillin 96.4 3.6
imipenem 98.6 1.4
ertapenem 76.3 23.7
cefoxitin 76.3 23.7
cefotaxim 43.9 18.0 38.1
clindamycin 48.2 51.8
tetracyclin 69.0 13.7 17.3
tigecyclin 96.4 1.4 2.2
moxifloxacin 49.0 49.6 1.4
aAntibiotic susceptibility testing was performed using the disk-diffusion
method. The antibiotic disks used were amoxicillin, amoxicillin-clavulanic acid,
piperacillin, piperacillin-tazobactam, ertapenem, imipenem, cefoxitine,
cefotaxim, clindamycine, tetracycline, tigecycline, chloramphenicol,
moxifloxacin, metronidazole, linezolide, and vancomycin.
Data corresponding to 100% susceptibility among strains of one species are not
presented.
bS, susceptible ; I, intermediate ; R, resistant.
cClostridium spp: C. baratii (n=3); C. tertium (n=3); C. disporicum (n=2);
Robinsoniella peoriensis (n=2);C. glycolicum (n=1); C. orbiscindens (n=1).
doi:10.1371/journal.pone.0030594.t002
Figure 2. Comparison of clostridia species recovery in antibi-
otic exposed and non exposed premature neonates included
in the study. Numbers correspond to the non redundant strains
isolated (non redundant strains were defined as strains isolated from
one individual and belonging to one species).
doi:10.1371/journal.pone.0030594.g002
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study of Schwiertz et al. [36] who reported an increase in the
similarity of the bacterial communities of PN during their hospital
stays.
In conclusion, this study shows that, by contrast with other
anaerobes, clostridia are part of the PN gut microbiota. The high
prevalence of this genus in PN is therefore not linked to a high
degree of resistance to antimicrobial agents and to the wide use of
antibiotics in NICUs. The perinatal determinant influencing PN
clostridia colonization appears to be the NICU environment. This
study gives new insights on the factors of colonization of clostridia
species and may participate to better understand neonatal
gastrointestinal infections involving clostridia.
Acknowledgments
We would like to thank Ioannis Nicolis for helping us with statistical
analysis.
Author Contributions
Conceived and designed the experiments: LF MJB JA. Performed the
experiments: LF JA. Analyzed the data: LF MJB JA JCR. Contributed
reagents/materials/analysis tools: LF MJB JA FC JCR MV. Wrote the
paper: LF JA MJB.
References
1. Johnson EA, Summanen P, Finegold SM (2007) Clostridium. In: Murray PR,
Baron AJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of Clinical
Microbiology. Washington, D.C.: ASM Press. pp 889–910.
2. Brook I (1995) Clostridial infection in children. J Med Microbiol 42: 78–82.
3. Brook I (2010) The role of anaerobic bacteria in bacteremia. Anaerobe 16:
183–189.
4. Kosloske AM, Ulrich JA, Hoffman H (1978) Fulminant necrotising enterocolitis
associated with clostridia. Lancet 2: 1014–1016.
5. Cashore WJ, Peter G, Lauermann M, Stonestreet BS, Oh W (1981) Clostridia
colonization and clostridia toxin in neonatal necrotizing enterocolitis. J Pediatr
98: 308–311.
6. Sturm R, Staneck JL, Stauffer LR, Neblett III WW (1980) Neonatal necrotizing
enterocolitis associated with penicillin-resistant, toxigenic Clostridium butyricum.
Pediatrics 66: 928–931.
7. Alfa MJ, Robson D, Davi M, Bernard K, Van Caeseele P, et al. (2002) An
outbreak of necrotizing enterocolitis associated with a novel Clostridium species in
a neonatal intensive care unit. Clin Infect Dis 35: S101–S105.
8. Obladen M (2009) Necrotizing enterocolitis–150 years of fruitless search for the
cause. Neonatology 96: 203–210.
9. Neu J, Walker WA (2011) Necrotizing enterocolitis. N Engl J Med 364:
255–264.
10. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, et al. (2011) Fecal
microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 6:
e20647.
11. Howard FM, Bradley JM, Flynn DM, Noone P, Szawatkowski M (1977)
Outbreak of necrotizing enterocolitis caused by Costridium butyricum. Lancet. pp
1099–1102.
12. Kosloske AM, Ball WS, Jr., Umland E, Skipper B (1985) Clostridial necrotizing
enterocolitis. J Pediatr Surg 20: 155–159.
13. Brook I, Avery G, Glasgow A (1982) Clostridium difficile in paediatric infections.
J Infect 4: 253–257.
14. Blakey JL, Lubitz L, Campbell NT, Gillam GL, Bishop RF, et al. (1985) Enteric
colonization in sporadic neonatal necrotizing enterocolitis. J Pediat Gastro-
enterol Nutr 4: 591–595.
15. De La Cochetie `re MF, Piloquet H, Des Robert C, Darmaun D, Galmiche JP,
et al. (2004) Early intestinal bacterial colonization and necrotizing enterocolitis
in premature infants: the putative role of Clostridium. Pediatr Res 56: 1–5.
16. Waligora-Dupriet AJ, Dugay A, Auzeil N, Huerre M, Butel MJ (2005) Evidence
for clostridial implication in experimental necrotising enterocolitis through
bacterial fermentation in a gnotobiotic quail model. Pediatr Res 58: 629–635.
17. Smith B, Bode S, Petersen BL, Jensen TK, Pipper C, et al. (2011) Community
analysis of bacteria colonizing intestinal tissue of neonates with necrotizing
enterocolitis. BMC Microbiol 11: 73.
18. Campeotto F, Suau A, Kapel N, Magne F, Viallon V, et al. (2011) A fermented
formula in preterm infants: clinical tolerance, gut microbiota, down-regulation of
faecal calprotectin and up regulation of faecal secretory IgA. Br J Nutr 105:
1843–1851.
19. Rouge C, Piloquet H, Butel MJ, Berger B, Rochat F, et al. (2009) Oral
supplementation with probiotics in very-low-birth-weight preterm infants: a
randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 89:
1828–1835.
20. Jacquot A, Neveu D, Aujoulat F, Mercier G, Marchandin H, et al. (2011)
Dynamics and clinical evolution of bacterial gut microflora in extremely
premature patients. J Pediatr 158: 390–396.
21. Claud EC, Walker WA (2001) Hypothesis: inappropriate colonization of the
premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 15:
1398–1403.
22. Siggers RH, Siggers J, Thymann T, Boye M, Sangild PT (2011) Nutritional
modulation of the gut microbiota and immune system in preterm neonates
susceptible to necrotizing enterocolitis. J Nutr Biochem 22: 511–521.
23. Butel MJ, Roland N, Hibert A, Popot F, Favre A, et al. (1998) Clostridial
pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and
protective role of bifidobacteria. J Med Microbiol 47: 391–399.
24. de Vos N, Mevissen-Verhage E, Harmsen van Amerongen W, Marcelis J (1982)
A new selective medium for the culture of clostridia from human feces. Eur J Clin
Microbiol 1: 267–271.
25. Woo PC, Lau SK, Chan KM, Fung AM, Tang BS, et al. (2005) Clostridium
bacteraemia characterised by 16S ribosomal RNA gene sequencing. J Clin
Pathol 58: 301–307.
26. Comite ´ de l’antibiogramme de la Socie ´te ´ Fanc ¸aise de Microbiologie (CA-SFM)
(2010) Available: http://www.sfm-microbiologie.org/UserFiles/file/CASFM/
casfm_2010.pdf. Accessed 2012 Jan 6.
27. Rotimi VO, Olowe SA, Ahmed I (1985) The development of bacterial flora of
premature neonates. J Hyg (Lond) 94: 309–318.
28. Stark PL, Lee A (1982) The bacterial colonization of the large bowel of pre-term
low birth weight neonates. J Hyg Camb 89: 59–67.
29. Blakey JL, Lubitz L, Barnes GL, Bishop RF, Campbell NT, et al. (1982)
Development of gut colonisation in preterm neonates. J Med Microbiol 15:
519–529.
30. Bennet R, Eriksson M, Nord CE, Zetterstrom R (1986) Fecal bacterial
microflora of newborn infants during intensive care management and treatment
with five antibiotic regimens. Pediatr Infect Dis 5: 533–539.
31. Roudiere L, Jacquot A, Marchandin H, Aujoulat F, Devine R, et al. (2009)
Optimized PCR-Temporal Temperature Gel Electrophoresis compared to
cultivation to assess diversity of gut microbiota in neonates. J Microbiol Methods
79: 156–165.
32. Chang JY, Shin SM, Chun J, Lee JH, Seo JK (2011) Pyrosequencing-based
Molecular Monitoring of the intestinal bacterial colonization in preterm infants.
J Pediatr Gastroenterol Nutr 53: 512–519.
33. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, et al. (2009) 16S rRNA
gene-based analysis of fecal microbiota from preterm infants with and without
necrotizing enterocolitis. ISME J 3: 944–954.
34. Magne F, Abely M, Boyer F, Morville P, Pochart P, et al. (2006) Low species
diversity and high inter individual variability in faeces of preterm infants as
revealed by sequences of 16S rRNA genes and PCR-temporal temperature
gradient gel electrophoresis profiles. FEMS Microbiol Ecol 57: 128–138.
35. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, et al. (2010) Intestinal
microbial ecology in premature infants assessed with non-culture-based
techniques. J Pediatr 156: 20–25.
36. Schwiertz A, Gruhl B, Lobnitz M, Michel P, Radke M, et al. (2003)
Development of the intestinal bacterial composition in hospitalized preterm
infants in comparison with breast fed, full-term infants. Pediatr Res 54: 393–399.
37. Morowitz MJ, Poroyko V, Caplan M, Alverdy J, Liu DC (2010) Redefining the
role of intestinal microbes in the pathogenesis of necrotizing enterocolitis.
Pediatric 125: 777–785.
38. Kalia VC, Mukherjee T, Bhushan A, Joshi J, Shankar P, et al. (2011) Analysis of
the unexplored features of rrs (16S rDNA) of the Genus Clostridium.B M
Genomics 12: 18.
39. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, et al.
(1994) The phylogeny of the genus Clostridium: proposal of five new genera and
eleven new species combinations. Int J Syst Bacteriol 44: 812–826.
40. Millar MR, Linton CJ, Cade A, Glancy D, Hall M, et al. (1996) Application of
16S rRNA gene PCR to study bowel flora of preterm infants with and without
necrotizing enterocolitis. J Clin Microbiol 34: 2506–2510.
41. Butel MJ, Suau A, Campeotto F, Magne F, Aires J, et al. (2007) Conditions of
bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr
Gastroenterol Nutr 44: 577–582.
42. Bjornvad CR, Thymann T, Deutz NE, Burrin DG, Jensen SK, et al. (2008)
Enteral feeding induces diet-dependent mucosal dysfunction, bacterial prolifer-
ation, and necrotizing enterocolitis in preterm pigs on parenteral nutrition.
Am J Physiol Gastrointest Liver Physiol 295: G1092–G1103.
43. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN (2000) An
antibiotic policy to prevent emergence of resistant bacilli. Lancet 355: 973–978.
44. Goldstein EJ, Citron DM (2009) Activity of a novel carbapenem, doripenem,
against anaerobic pathogens. Diagn Microbiol Infect Dis 63: 447–454.
Gut Clostridial Colonization in Premature Neonates
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e3059445. Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrell K, et al. (2003) In
vitro activities of dalbavancin and nine comparator agents against anaerobic
gram-positive species and corynebacteria. Antimicrob Agents Chemother 47:
1968–1971.
46. Mutlu E, Wroe AJ, Sanchez-Hurtado K, Brazier JS, Poxton IR (2007)
Molecular ,characterization and antimicrobial susceptibility patterns of Clostrid-
ium difficile strains isolated from hospitals in south-east Scotland. J Med Microbiol
56: 921–929.
47. Magot M (1981) Some properties of the Clostridium butyricum group beta-
lactamase. J Gen Microbiol 127: 113–119.
48. Gro ¨nlund MM, Lehtonen OP, Eerola E, Kero P (1999) Fecal microflora in
healthy infants born by different methods of delivery: permanent changes in
intestinal flora after cesarean delivery. J Pediat Gastroenterol Nutr 28: 19–25.
49. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, et al. (2006) Factors
influencing the composition of the intestinal microbiota in early infancy.
Pediatrics 118: 511–521.
50. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, et al. (2010) Mode of
delivery affects the bacterial community in the newborn gut. Early Hum Dev 86
Suppl 1: 13–15.
51. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P (1999) Stool
microflora in extremely low birth weight infants. Arch Dis Child Fetal Neonatal
Ed 80: F167–F173.
52. Blondeau JM (2009) What have we learned about antimicrobial use and the risks
for Clostridium difficile-associated diarrhoea? J Antimicrob Chemother 63:
238–242.
Gut Clostridial Colonization in Premature Neonates
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30594